News
16h
Zacks Investment Research on MSNFDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV PillMerck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
19h
Interesting Engineering on MSNSpace startup raises millions to make ‘impossible’ drugs that Earth’s gravity won’t allowVarda Space Industries has raised $187 million to accelerate drug development in space using microgravity technology.
Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
Durham was Nvidia’s first office location outside of California. A former employee at its Durham location shares what working ...
Neutralizing Antibody Market is estimated to valued at USD 243.93 Bn in 2025 and expected reach USD 434.58 Bn by 2032, growing at CAGR of 8.6% from 2025 to 2032. BURLINGAME, CA, U ...
13hon MSN
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - July 14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results